 VANCOUVER, British Columbia--BUSINESS WIRE--- ABCL AbCellera--Lilly to Supply the EU and EEA with up to 220,000 Doses of Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19 